163 related articles for article (PubMed ID: 26731207)
1. A Comparison of Immediate and Delayed Vitrectomy for the Management of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy.
Fassbender JM; Ozkok A; Canter H; Schaal S
Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):35-41. PubMed ID: 26731207
[TBL] [Abstract][Full Text] [Related]
2. Combined phacoemulsification, vitrectomy and endolaser photocoagulation in patients with diabetic retinopathy and cataract.
Wahab S; Das Hargun L
J Coll Physicians Surg Pak; 2014 Oct; 24(10):736-9. PubMed ID: 25327917
[TBL] [Abstract][Full Text] [Related]
3. Long-term visual and retinopathy outcomes in a predominately type 2 diabetic patient population undergoing early vitrectomy and endolaser for severe vitreous haemorrhage.
Ratnarajan G; Mellington F; Saldanha M; de Silva SR; Benjamin L
Eye (Lond); 2011 Jun; 25(6):704-8; quiz 709. PubMed ID: 21494282
[TBL] [Abstract][Full Text] [Related]
4. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
Chaudhry NA; Lim ES; Saito Y; Mieler WF; Liggett PE; Filatov V
Ophthalmology; 1995 Aug; 102(8):1164-9. PubMed ID: 9097742
[TBL] [Abstract][Full Text] [Related]
5. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
7. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
Khuthaila MK; Hsu J; Chiang A; DeCroos FC; Milder EA; Setlur V; Garg SJ; Spirn MJ
Am J Ophthalmol; 2013 Apr; 155(4):757-63, 763.e1-2. PubMed ID: 23317651
[TBL] [Abstract][Full Text] [Related]
8. Vitreous hemorrhage in diabetic eyes previously treated with panretinal photocoagulation.
Kleinmann G; Hauser D; Schechtman E; Landa G; Bukelman A; Pollack A
Int Ophthalmol; 2008 Feb; 28(1):29-34. PubMed ID: 17619829
[TBL] [Abstract][Full Text] [Related]
9. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.
Takayama K; Someya H; Yokoyama H; Takamura Y; Morioka M; Sameshima S; Ueda T; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Sci Rep; 2019 Oct; 9(1):14858. PubMed ID: 31619708
[TBL] [Abstract][Full Text] [Related]
11. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
Neely KA; Scroggs MW; McCuen BW
Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
[TBL] [Abstract][Full Text] [Related]
12. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
[TBL] [Abstract][Full Text] [Related]
13. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy.
Luttrull JK; Musch DC; Spink CA
Eye (Lond); 2008 May; 22(5):607-12. PubMed ID: 17293791
[TBL] [Abstract][Full Text] [Related]
14. [Application of endolaser in vitrectomy for retinal vascular disease].
Zang J; Zhou B; Bao J; Zhu Y; Lin W; Li Q; Bian Q; Zhang S; Gao R; He L
Yan Ke Xue Bao; 2003 Dec; 19(4):221-3. PubMed ID: 14740549
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
16. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
Li X; Jiang Y; Ye C; Li C
Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
[TBL] [Abstract][Full Text] [Related]
17. Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study.
Ostri C; Lux A; Lund-Andersen H; la Cour M
Acta Ophthalmol; 2014 Sep; 92(6):571-6. PubMed ID: 24373516
[TBL] [Abstract][Full Text] [Related]
18. Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab.
Hu X; Pan Q; Zheng J; Song Z; Zhang Z
BMC Ophthalmol; 2019 Sep; 19(1):200. PubMed ID: 31519158
[TBL] [Abstract][Full Text] [Related]
19. Use of pegaptanib for recurrent and non-clearing vitreous haemorrhage in proliferative diabetic retinopathy.
Hornan D; Edmeades N; Krishnan R; Khan J; Lochhead J
Eye (Lond); 2010 Aug; 24(8):1315-9. PubMed ID: 20224599
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage.
Huang YH; Yeh PT; Chen MS; Yang CH; Yang CM
Retina; 2009 Sep; 29(8):1134-40. PubMed ID: 19672218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
